Patent · US Active

Oral formulations

US8496967B2 · kind B2 · utility

1Cited by
32References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 23, 2009
Grant dateJul 30, 2013
Priority date—
Expiry dateApr 13, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A solid pharmaceutical composition containing AP23573 suitable for oral administration is disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.